Related Experiment Video
Updated: Jan 3, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
Gramicidin inhibits human gastric cancer cell proliferation, cell cycle and induced apoptosis
Tingting Chen1, Yong Wang2, Yang Yang1
1Department of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Anhui Province Key Laboratory of Translational Cancer Research (Bengbu Medical College), 287 Changhuai Road, Bengbu, 233004, Anhui Province, People's Republic of China.
Background:
Gastric cancer is a common malignant tumor with high morbidity and mortality worldwide, which seriously affects human health. Gramicidin is a short peptide antibiotic which could be used for treating infection induced by bacteria or fungi. However, the anti-cancer effect of gramicidin on gastric cancer cells and its underlying mechanism remains largely unknown.
Results:
Gastric cancer cells SGC-7901, BGC-823 and normal gastric mucosal cells GES-1 were treated with different concentrations of gramicidin respectively. The results of CCK-8 experiment revealed cellular toxicity of gramicidin to cancer cells while cell colony formation assay showed that gramicidin significantly inhibited the proliferation of gastric cancer cells, but had little effect on normal gastric mucosal cells. In addition, the wound healing assay showed that gramicidin inhibited the migration of SGC-7901 cell. Meanwhile, apoptosis and cell cycle analysis revealed that gramicidin induced cell apoptosis with G2/M cell cycle inhibition. Furthermore, western blot analysis demonstrated that gramicidin down-regulated the expression of cyclinD1 and Bcl-2 as well as the FoxO1 phosphorylation.
Conclusions:
The current study illustrated the anti-tumor activity of gramicidin on gastric cancer cells, providing a possibility for gramicidin to be applied in clinical practice for the treatment of gastric cancer.
Insights
Gramicidin exhibits anti-tumor effects against gastric cancer cells by inhibiting proliferation, migration, and inducing apoptosis. This peptide antibiotic shows potential for clinical application in treating gastric cancer.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Gastric cancer presents a significant global health challenge due to high morbidity and mortality.
- Gramicidin, a peptide antibiotic, is primarily known for its antimicrobial properties.
- The anti-cancer potential of gramicidin on gastric cancer remains largely unexplored.
Purpose of the Study:
- To investigate the anti-cancer effects of gramicidin on human gastric cancer cells.
- To elucidate the underlying mechanisms of gramicidin's action in gastric cancer.
- To evaluate gramicidin's potential as a therapeutic agent for gastric cancer.
Main Methods:
- Cell viability was assessed using CCK-8 assays.
- Cell proliferation was evaluated through colony formation assays.
- Cell migration, apoptosis, cell cycle, and protein expression (cyclinD1, Bcl-2, FoxO1 phosphorylation) were analyzed using wound healing, apoptosis/cell cycle analysis, and Western blot.
Main Results:
- Gramicidin demonstrated significant toxicity to gastric cancer cells (SGC-7901, BGC-823) while sparing normal gastric mucosal cells (GES-1).
- Gramicidin inhibited gastric cancer cell proliferation, migration, and induced apoptosis, with observed G2/M cell cycle arrest.
- Down-regulation of cyclinD1, Bcl-2, and FoxO1 phosphorylation was observed following gramicidin treatment.
Conclusions:
- Gramicidin exhibits significant anti-tumor activity against gastric cancer cells in vitro.
- Gramicidin's mechanism involves inhibiting proliferation and migration, inducing apoptosis, and affecting key cell cycle and survival proteins.
- These findings suggest gramicidin as a potential candidate for clinical application in gastric cancer treatment.
Related Concept Videos
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Negative Regulator Molecules
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

